Profil
Carlos E.
Ibañez was the founder of Abintus Bio, Inc. and served as Senior Vice President-CMC since 2020.
Former positions include Principal at Chiron Corp., Principal at Collateral Therapeutics, Inc., Principal at Activate Immunotherapy, Vice President-Product Development & Manufacturing at Tocagen, Inc., Principal at Chiron Viagene, Inc., and Member at Research Institute of Public Health.
Education includes a doctorate from the University of California San Diego.
Anciens postes connus de Carlos E. Ibañez
| Sociétés | Poste | Fin |
|---|---|---|
Abintus Bio, Inc.
Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Fondateur | 01/01/2025 |
Research Institute of Public Health | Corporate Officer/Principal | - |
Activate Immunotherapy
Activate Immunotherapy BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | - |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Corporate Officer/Principal | - |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | - |
Formation de Carlos E. Ibañez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Commercial Services |
Activate Immunotherapy
Activate Immunotherapy BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Tocagen, Inc.
Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Chiron Viagene, Inc.
Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial biotechnical research | Commercial Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Institute of Public Health | |
Abintus Bio, Inc.
Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Commercial Services |
















